| Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan | Bone marrow transplantation |  | | 2023 | 15 | 85 |
|
| A potential implication of UDP-glucuronosyltransferase 2B10 in the detoxification of drugs used in pediatric hematopoietic stem cell transplantation setting: an in silico investigation | BMC molecular and cell biology | | | 2022 | 80 | 289 |
|
| Cohort-based association study of germline genetic variants with acute and chronic health complications of childhood cancer and its treatment: Genetic Risks for Childhood Cancer Complications Switzerland (GECCOS) study protocol | BMJ open | | | 2022 | 74 | 109 |
|
| GSTM1 and GSTT1 double null genotypes determining cell fate and proliferation as potential risk factors of relapse in children with hematological malignancies after hematopoietic stem cell transplantation | Journal of cancer research and clinical oncology | | | 2022 | 395 | 212 |
|
| Is Busulfan Clearance Different in Patients With Sickle Cell Disease? Let's Clear Up That Case With Some Controls | Journal of pediatric hematology/oncology |  | | 2021 | 316 | 0 |
|
| Genetic susceptibility to acute graft versus host disease in pediatric patients undergoing HSCT | Bone marrow transplantation | | | 2021 | 283 | 2 |
|
| ABO incompatibile graft management in pediatric transplantation | Bone marrow transplantation | | | 2021 | 230 | 1 |
|
| Supportive Care During Pediatric Hematopoietic Stem Cell Transplantation: Prevention of Infections. A Report From Workshops on Supportive Care of the Paediatric Diseases Working Party (PDWP) of the European Society for Blood and Marrow Transplantation (EBMT) | Frontiers in pediatrics | | | 2021 | 341 | 574 |
|
| Genetic Predictors for Sinusoidal Obstruction Syndrome - A Systematic Review | Journal of personalized medicine | | | 2021 | 268 | 199 |
|
| The analysis of GSTA1 promoter genetic and functional diversity of human populations | Scientific reports | | | 2021 | 287 | 407 |
|
| Predictors for participation in DNA self-sampling of childhood cancer survivors in Switzerland | BMC Medical research methodology | | | 2021 | 255 | 205 |
|
| Precision dosing of intravenous busulfan in pediatric hematopoietic stem cell transplantation: Results from a multicenter population pharmacokinetic study | CPT: pharmacometrics & systems pharmacology | | | 2021 | 250 | 245 |
|
| Genetic Susceptibility to Hepatic Sinusoidal Obstruction Syndrome in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | | | 2020 | 348 | 0 |
|
| The Biological and Clinical Relevance of G Protein-Coupled Receptors to the Outcomes of Hematopoietic Stem Cell Transplantation: A Systematized Review | International Journal of Molecular Sciences | | | 2019 | 341 | 353 |
|
| Challenges on the diagnostic approach of inherited platelet function disorders: Is a paradigm change necessary? | Platelets | | | 2018 | 348 | 0 |
|
| Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation | British Journal of Clinical Pharmacology | | | 2018 | 380 | 244 |
|
| GSTA1 Genetic Variants and Conditioning Regimen: Missing Key Factors in Dosing Guidelines of Busulfan in Pediatric Hematopoietic Stem Cell Transplantation | Biology of Blood and Marrow Transplantation | | | 2017 | 503 | 17 |
|
| GSTA1 diplotypes affect busulfan clearance and toxicity in children undergoing allogeneic hematopoietic stem cell transplantation: a multicenter study | Oncotarget | | | 2017 | 562 | 341 |
|
